ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

RedDr. Introduces ArchPad Featuring Patented Six-Level Arch Support System

By: Get News
RedDr. introduces ArchPad, a medical-grade footcare product designed to reduce fatigue through a six-level customizable arch support system. The product recently reached a top 0.1% sales rank on Amazon in the Sports Accessories category.

RedDr., a South Korean health and wellness brand, has officially announced the launch of ArchPad, a next-generation insole featuring a patented six-level adjustable arch support system. On November 29, 2024, the product reached the top 0.1% rank on Amazon within the Sports Accessories category, representing a key milestone for its global expansion.

Designed to address chronic foot fatigue and structural imbalances, ArchPad targets one of the most widespread yet overlooked health concerns: poor foot posture and pain due to prolonged standing or walking. The ArchPad allows users to adjust both the height and firmness of the arch structure to suit flat feet, normal arches, or high arches, offering a tailored approach to foot alignment.

Unlike traditional insoles that merely provide cushioning, ArchPad delivers dynamic mid-foot stimulation with every step. This helps to activate foot muscles, realign body posture, and reduce inflammation caused by poor foot mechanics. The design is compatible with sneakers, casual shoes, and even slippers.

The product incorporates six core functional features:

1. Six-Level Adjustable Arch Support

Each ArchPad includes a patented modular support system with 6 removable arch inserts, allowing users to adjust both height and firmness to match their natural arch. This helps re-align the foot, ankle, knee, and hip for full-body posture correction.

2. Midfoot Stimulation Technology

Encourages circulation and relieves pain through targeted pressure on the medial arch.

3. Weight Redistribution

Design Relieves pressure from the heel and forefoot by elevating the arch and stabilizing the heel.

4. Antibacterial, Odor-Resistant Materials

EVA and mesh prevent bacterial growth for long-lasting freshness.

5. Endurance-Tested Durability

Withstands over 1 million flexes without losing shape or support.

6. Universal Fit and Adhesive Grip

Stays in place during daily wear in most types of footwear.

According to RedDr., more than 75% of adults begin to experience foot dysfunction by age 40. ArchPad aims to offer a proactive, accessible alternative to custom orthotics, which are often expensive and difficult to obtain.

"Our mission was to create a footcare product that combines science, comfort, and long-term durability," said Min Kyungjoon, CEO of RedDr.'s parent company, Dispis. "ArchPad is a reflection of our dedication to solving everyday health challenges with precision and innovation."

RedDr. ArchPad is currently available in international markets and has achieved notable success on Amazon and Rakuten Japan, where it ranked #1 in the insole category.

Media Contact
Company Name: Dispis Co., Ltd.
Contact Person: Min Kyungjoon
Email: Send Email
Country: South Korea
Website: https://www.reddr.co.kr/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.